Iressa 250 mg tablets contain gefitinib, a targeted therapy for treating non-small cell lung cancer. As an EGFR inhibitor, it blocks signals that encourage cancer cell growth. Prescribed under medical supervision, the dosage may vary based on individual factors. Potential side effects and interactions should be discussed with a healthcare professional.